Clinical Trial Search

Primary: Number of Patients Requiring Catheterization for Urinary Retention Secondary to Treatment. — 0 participants

Primary: Number of Subjects With Evidence of Bacteria in Urine Sample by Microbiologic Evaluation — 8; 1 participants

Primary: Urethral Sphincter Pressure — 50 cmH2O

Primary: Change From Baseline in Treatment Response as Measured by the Total Score on the O'Leary-Sant Questionnaire — -6.7; -5.8 scores on a scale

Primary: Proportion of Measures Adhered To in the PD Guidelines — 0.77; 0.58 proportion of quality measures followed — p=>0.05

Primary: Change in O'Leary-Sant Interstitial Cystitis Symptom Index Score — -4.25; -6.2; 0; -1.8 units on a scale

Primary: Proportion of Patients Experiencing Severe Acute Non-genitourinary Side Effects Following Radiotherapy. — 4; 2 Participants

Primary: Changes in Brain Activity After Treatment Measured Using Functional MRI — 2.759234; 3.423569; 3.000987; 3.094914 BOLD fMRI T-Value — p=<0.05

Primary: Percentage of Patients With Complete Pathologic Response After 3 Cycles of Treatment — 27.3 percentage of patients

Primary: Change in Overactive Bladder Symptoms (Based on OABqSF) — -19; -33.4 units on a scale — p=.07

Primary: Global Response Assessment (GRA) — 5.25; 4; 4.6; 5.1 units on a scale

Primary: Average Catheterization Urine Volume — 95.3; 114.0; 30.0; 52.4 mL

Primary: Evaluate Subjective Patient Change in Irritative Urinary Symptoms as Measured by the Overactive Bladder Questionnaire (OAB-q) Symptom Bother Score — 65.4; 61.6; 46.7…

Primary: Change From Baseline to End of Treatment (EoT) in Mean Volume Voided (MVV) Per Micturition — 13.4; 25.5; 6.9; 2.3 mL — p=0.046

Primary: Number of Micturations Per 24 Hour Period — 8.78; 9.19; 8.00; 8.94 Number of micturations per 24 hours — p=0.53